https://www.selleckchem.com/products/adt-007.html
CTCs acquire a survival advantage through phenotypic alterations in the hostile blood environment, and evade circulatory immune surveillance. Prognosis of patients with unresectable squamous cell carcinomas of the head and neck requires improvement. This retrospective study compared accelerated radiotherapy plus chemotherapy to conventional radiochemotherapy. Patients received definitive treatment with accelerated radiotherapy plus chemotherapy (group A, n=1 or conventional cisplatin-based radiochemotherapy (group B, n=85). Groups wer
Like
Comment
Share
